Kintara Therapeutics, Inc. ("Kintara") a biopharmaceutical company focused on the development of new solid tumor cancer therapies, encourages all stockholders to vote at the upcoming Special Meeting ...

The sale was disclosed in a filing with the Securities ... The Goldman Sachs Group reduced their price target on Tesla from $248.00 to $230.00 and set a “neutral” rating on the stock in ...

Analyst Travis Steed of Bank of America Securities maintained a Buy rating on Medtronic (MDT – Research Report), retaining the price ...

Medtronic PLC closed $2.15 below its 52-week high ($91.49), which the company reached on September 4th.

In a report released yesterday, Larry Biegelsen from Wells Fargo maintained a Buy rating on Medtronic (MDT – Research Report), with a ...

Medtronic sent all affected customers an Urgent Medical Device Sale Removal and Correction Letter recommending the return of devices to Medtronic after disposing of the battery assembly.

Runners will line up in downtown Minneapolis before winding through the Twin Cities to the Minnesota State Capitol.

Shares of Medtronic PLC MDT advanced 1.52% to $89.47 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index SPX rising 1.70% to 5,713.64 ...